Abstract
Background
There is no clear evidence on the prevention of postoperative delirium with pharmacotherapy in elderly patients with esophageal cancer. This retrospective study aimed to evaluate the efficacy of ramelteon and suvorexant in preventing postoperative delirium in this patient group.
Methods
Data on 251 patients who received radical esophagectomy for thoracic esophageal cancer were collected from January 2010 to September 2021. In total, 74 patients did not receive preventive intervention, and 177 received ramelteon and suvorexant. After propensity score matching, the rate of postoperative delirium was compared between the two groups.
Results
Seventy-two well-balanced patients in each group demonstrated similar clinical and pathological characteristics. The mean ages of the intervention and control groups were 70.8 and 70.3 years, respectively. All the patients underwent McKeown esophagectomy, and in the volume of intraoperative blood loss or operative time did not significantly differ between the two groups. The incidence rates of postoperative hyperactive delirium were 7% (5/72) in the intervention group and 32% (23/72) in the control group (p < 0.001). No severe adverse event potentially attributable to the intervention drug was observed. The multivariate analysis showed that the use of ramelteon and suvorexant was the only independent protective factor against postoperative delirium (hazard ratio 0.157, 95% CI 0.055–0.448, p < 0.001).
Conclusions
Ramelteon and suvorexant may play an important role in reducing postoperative delirium in elderly patients with esophageal cancer.
Similar content being viewed by others
References
Fuchita M, Khan SH, Perkins AJ, et al. Perioperative risk factors for postoperative delirium in patients undergoing esophagectomy. Ann Thorac Surg. 2019;108:190–5.
Takeuchi M, Takeuchi H, Fujisawa D, et al. Incidence and risk factors of postoperative delirium in patients with esophageal cancer. Ann Surg Oncol. 2012;19:3963–70.
Inouye SK, Bogardus ST Jr, Charpentier PA, et al. A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med. 1999;340:669–76.
Nair NP, Hariharasubramanian N, Pilapil C, Isaac I, Thavundayil JX. Plasma melatonin–an index of brain aging in humans? Biol Psychiatry. 1986;21:141–50.
Hamasaki MY, Barbeiro HV, Barbeiro DF, et al. Neuropeptides in the brain defense against distant organ damage. J Neuroimmunol. 2016;290:33–5.
Al Aama T, Brymer C, Gutmanis I, et al. Melatonin decreases delirium in elderly patients: a randomized, placebo-controlled trial. Int J Geriatric Psychiatry. 2011;26:687–94.
Hatta K, Kishi Y, Wada K, et al. Preventive effects of ramelteon on delirium: a randomized placebo-controlled trial. JAMA Psychiat. 2014;71:397–403.
Hatta K, Kishi Y, Wada K, et al. Preventive effects of suvorexant on delirium: a randomized placebo-controlled trial. J Clin Psychiatry. 2017;78:e970–9.
Hatta K, Kishi Y, Wada K, et al. Real-world effectiveness of ramelteon and suvorexant for delirium prevention in 948 patients with delirium risk factors. J Clin Psychiatry. 2019;81(1):19m12865. https://doi.org/10.4088/JCP.19m12865.
Haneda R, Booka E, Ishii K, et al. Evaluation of definitive chemoradiotherapy versus radical esophagectomy in clinical t1bn0m0 esophageal squamous cell carcinoma. World J Surg. 2021;45:1835–44.
Mayanagi S, Haneda R, Inoue M, Ishii K, Tsubosa Y. Selective lymphadenectomy for salvage esophagectomy in patients with esophageal squamous cell carcinoma. Ann Surg Oncol. 2022;29:4863–70.
Ishii K, Tsubosa Y, Nakao J, et al. Utility of the evaluation of blood flow of remnant esophagus with indocyanine green in esophagectomy with jejunum reconstruction: case series. Ann Med Surg. 2021;62:21–5.
Kato K, Ito Y, Daiko H, et al. A randomized controlled phase III trial comparing two chemotherapy regimen and chemoradiotherapy regimen as neoadjuvant treatment for locally advanced esophageal cancer, jcog1109 next study. J Clin Oncol. 2022;40(4_suppl):238–238.
American Psychiatric Association. The diagnostic and statistical manual of mental disorders, fifth edition (DSM-5). 2013.
Bickel H, Gradinger R, Kochs E, et al. High risk of cognitive and functional decline after postoperative delirium. Dement Geriatr Cogn Disord. 2008;26:26–31.
Ely EW. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA. 2004;291:1753–62.
Robinson T, Raeburn C, Tran Z, et al. Postoperative delirium in the elderly: risk factors and outcomes. Ann Surg. 2009;249:173–8.
Rudolph J, Inouye S, Jones R, et al. Delirium: an independent predictor of functional decline after cardiac surgery. J Am Geriatr Soc. 2010;58:643–9.
Saczynski J, Marcantonio E, Quach L, et al. Cognitive trajectories after postoperative delirium. N Engl J Med. 2012;367:30–9.
Witlox J, Eurelings LSM, de Jonghe JFM, et al. Delirium in elderly patients and the risk of postdischarge mortality, institutionalization, and dementia: a meta-analysis. JAMA. 2010;304:443–51.
Siddiqi N, Harrison JK, Clegg A, et al. Interventions for preventing delirium in hospitalised non-icu patients. Cochrane Database Syst Rev. 2016;3:Cd005563.
Abraha I, Trotta F, Rimland JM, et al. Efficacy of non-pharmacological interventions to prevent and treat delirium in older patients: a systematic overview. The senator project ontop series. PLoS One. 2015;10:e0123090.
Zhang H, Lu Y, Liu M, et al. Strategies for prevention of postoperative delirium: a systematic review and meta-analysis of randomized trials. Crit Care. 2013;17:R47.
Khan BA, Perkins AJ, Campbell NL, et al. Preventing postoperative delirium after major noncardiac thoracic surgery-a randomized clinical trial. J Am Geriatr Soc. 2018;66:2289–97.
Avidan MS, Maybrier HR, Abdallah AB, et al. Intraoperative ketamine for prevention of postoperative delirium or pain after major surgery in older adults: an international, multicentre, double-blind, randomised clinical trial. Lancet. 2017;390:267–75.
Gamberini M, Bolliger D, Lurati Buse GA, et al. Rivastigmine for the prevention of postoperative delirium in elderly patients undergoing elective cardiac surgery–a randomized controlled trial. Crit Care Med. 2009;37:1762–8.
Leung JM, Sands LP, Chen N, et al. Perioperative gabapentin does not reduce postoperative delirium in older surgical patients: a randomized clinical trial. Anesthesiology. 2017;127:633–44.
Wei W, Zhang A, Liu L, et al. Effects of subanaesthetic s-ketamine on postoperative delirium and cognitive function in elderly patients undergoing non-cardiac thoracic surgery: a protocol for a randomised, double-blinded, placebo-controlled and positive-controlled, non-inferiority trial (sked trial). BMJ Open. 2022;12: e061535.
Maldonado JR. Neuropathogenesis of delirium: review of current etiologic theories and common pathways. Am J Geriatr Psychiatry. 2013;21:1190–222.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
IRB/ERB/EC approval
This study was approved by the Institutional Review Board of Shizuoka Cancer Center Hospital (J2022-62-2022-1-3).
Conflict of interest
The authors declare no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Mayanagi, S., Haneda, R., Inoue, M. et al. Ramelteon and suvorexant for postoperative delirium in elderly patients with esophageal cancer. Esophagus 20, 635–642 (2023). https://doi.org/10.1007/s10388-023-01019-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10388-023-01019-7